Background illustration for clinical trials search

Paid Clinical Trials Fort Smith

Discover 128 paid clinical trials in Fort Smith, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Family Model DSME in FBOs in the RMI

for
Diabetes Mellitus, Type 2
Location: Springdale AR
Sponsor: University of Arkansas

Sex: All

Age: 18+

Code: NCT05502016

Recruiting

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

for
Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)
Location: Springdale AR, Tulsa OK, Edmond OK, Dallas TX, Tyler TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 50 - 70+

Code: NCT06541704

Phase3, Recruiting
Featured

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

for
Atopic Dermatitis
Location: Fayetteville AR, Dallas TX, Tyler TX, Mesquite TX,
Sponsor: AbbVie

Sex: All

Age: 18 - 63

Code: NCT06389136

Phase3, Recruiting

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

for
Atopic Dermatitis
Location: Fort Smith AR, Dallas TX, Arlington TX, Saint Joseph MO,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06947993

Phase2, Recruiting

Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age

for
Pneumococcal Immunization, Healthy Volunteers
Location: Fayetteville AR, Richmond TX, Bardstown KY, Edinburg TX,
Sponsor: Sanofi

Sex: All

Age: 0

Code: NCT07348692

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

PEN-866 in Patients With Advanced Solid Malignancies

for
Carcinoma, Endometrial Adenocarcinoma, Neoplasms,
Location: Springdale AR, Oklahoma City OK, Germantown TN,
Sponsor: Tarveda Therapeutics

Sex: All

Age: 18+

Code: NCT03221400

Phase1, Phase2, Recruiting

A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer

for
Platinum-resistant Ovarian Cancer
Location: Springdale AR, Rochester MN, Detroit MI, Sarasota FL,
Sponsor: Stemline Therapeutics, Inc.

Sex: Female

Age: 18+

Code: NCT07226427

Phase1, Recruiting

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

for
Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD
Location: Springdale AR, Edmond OK, Dallas TX, Tyler TX,
Sponsor: Adverum Biotechnologies, Inc.

Sex: All

Age: 50+

Code: NCT07482176

Phase3, Recruiting